REFERENCES
- Gama G, Santos A, Polania J. Measurement of trough-to-peak ratios of four anti-hypertensive drugs on the basis of 24h ambulatory blood pressure monitoring: different methods may give different results. J Hum Hypertens 1995;9:575–580.
- White WB. Analysis of ambulatory BP data in anti-hypertensive drug trials. J Hypertens 1991;9(suppl 1):S27–S32.
- Proposed Guidelines for the Clinical Evaluation of Antihypertensive Drugs. Food and Drug Administration, Division of Cardio-Renal Drug Products, Rockville, MD, draft, 1998.
- Rose M, McMahon FG. Some problems with anti-hypertensive drug studies in the context of the new guidelines. Am J Hypertens 1990;3:151–155.
- Sokolow M, Werdegar D, Kain HK, Hinman AT. Relationship between level of BP measured casually and portable recorders and severity of complications in essential hypertension. Circulation 1966;34:279–298.
- Mancia G, Zanchetti A, Agabiti-Rosei E, GBenemio G, R Cesaris RD, Fogari R, Pessino A, Porcellati C, Salvett AI, and Trimarco B. Ambulatory BP is superior to clinic BP in predicting treatment-induced regression of left ventricular hypertrophy. SAMPLE Study Group. Study on Ambulatory Monitoring of blood pressure and Lisinopril Evaluation. Circulation 1997;95:1464–1470.
- Ohkubo T, Obara T, Funahashi J, Kikuya M, Asayama K, Metoki H, Oikawa T, Takahashi H, Hashimoto J, Totsune K, Imai Y and the J-HOME Study Group: Control of blood pressure as measured at home and office, and comparison with physicians’ assessment of control among treated hypertensive patients in Japan: First Report of the Japan Home versus Office Blood Pressure Measurement Evaluation (J-HOME) Study. Hypertens Res 2004;27(10):755–763
- Ogihara T, Kikuchi K, Matsuoka H, Fujita T, Horiuchi M, Imai Y, Imaizumi T, Ito S, Iwao H, Kario K, Kawano Y, Kim-Matsuyama S, Kimura G, Matsubara H, Matsuura H, Naruse M, Saito I, Shimada K, Shimamoto K, Suzuki H, Takishita S, Tanahashi N, Tsuchihashi T, Uchiyama M, Ueda S, Ueshima H, Umemura S,Ishimitsu T, Rakugi H and Japanese Society of Hypertension. The Japanese Society of Hypertension Guidelines for the management of hypertension (JSH2009). Hypertens Res 2009;32(1):3–107.
- Japanese Society of Circulation. Guidelines for the 24-hour Ambulatory Blood Pressure Monitoring (ABPM) Jpn Circ J 2000;64(suppl V):1207–1248.
- Sega R, Facchetti R, Bonbelli M, Cesana G, Corrao G, Grassi G, and Mancia G. Prognostic value of ambulatory and home blood pressure compared with office blood pressure in the general population: follow-up results from the Pressioni Arteriose Monitorale e Loro Associazioni (PAMELA) study. Circulation 2005;111:1777–1783.
- Tachibana R, Tabara Y, Kondo I, Miki T and Kohara K. Home blood pressure is a better predictor of carotid atherosclerosis than office blood pressure in community-dwelling subjects. Hypertens Res 2004;27:633–639.
- Frattola A. Prognostic value of 24 hour blood pressure variability. J Hypertens 1993;11:1133–1137.
- Ombonis S. Prognostic value of ambulatory blood pressure monitoring. J Hypertens 1991;9(suppl 3):25S–28S.
- Floras JS, Jones JV, Hassan MD, Osikowska B, Sever PS, Sleight P. Cuff and ambulatory blood pressure in subjects with essential hypertension. Lancet 1981;ii:107–109.
- Furberg CD, Psaty BM, Meyer JV. Nifedipine. Dose-Related Increase in Mortality in Patients With Coronary Heart Disease. Circulation 1995;92:1326–1331.
- Hollenberg SM. Acute Coronary Syndromes. ACCP Crit Care Med Brd Rev 2009;20:129–144.
- Anderson L, Adams CD, Antman EM, Bridges CR, Califf RM, Casey Jr DE, Chavey II WE, Fesmire FM, Hochman JS, Levin TN. ACC/AHA 2007 Guidelines for the Management of patients with unstable angina/non-ST-elevation myocardial infarction: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol 2007;50:652–726
- Leenen FHH, Nwachuku CE, Black HR, Cushman WC, Davis BR, Simpson LM, Alderman MH, Atlas SA, Basile JN, Cuyjet AB. Clinical events in high-risk hypertensive patients randomly assigned to calcium channel blocker versus angiotensin-converting enzyme inhibitor in the antihypertensive and lipid-lowering treatment to prevent heart attack trial. Hypertension 2006; 48:374–384.
- Ryuzaki M, Nakamoto H, Nishida E, Sone M, Nakajima S, Yoshimoto M, Suzuki Y, Itagaki K. Crossover study of amlodipine versus nifedipine CR with home blood pressure monitored via cellular phone: internet-mediated open-label crossover trial of calcium channel blockers for hypertension -i-TECHO trial-. J Hypertens 2007;25:2352–2358.